(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ARCELLX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ARCELLX

ST13

US500000097208593

Class

5

Filing

97208593

Registration

7300306

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

02/13/2024

Trademark type

Combined

Nice classes

5

Filing date

01/07/2022

Registration date

02/06/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/06/2024

Last transaction

02/13/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2020-02-00

First use in commerce

2020-05-00

Drawing code

3

Owner type

03

Owner location

Redwood City, CA, US

Examiner

AIKENS, RONALD

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of "ARCELLX" in navy blue in stylized form. To the left are two overlapping bars, one in purple and the other in a blue gradient that transitions to purple.

Holders and representatives

Holders

Arcellx, Inc.
Arcellx, Inc.

Representatives

Aaron D. Hendelman Wilson Sonsini Goodrich & Rosati

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for treating cancer; pharmaceutical preparations for the purpose of binding ligands using receptors for treating cancer; pharmaceutical preparations for immunotherapy using genetically engineered cells for treating cancer

Publications

History of USPTO decisions and trademark events.

36 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/13/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/13/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/13/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/13/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/13/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/06/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/06/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/04/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/03/2024

DOCK

ASSIGNED TO EXAMINER

12/07/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/07/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/07/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/27/2023

IUAF

USE AMENDMENT FILED

10/25/2023

EISU

TEAS STATEMENT OF USE RECEIVED

10/25/2023

EX1G

SOU EXTENSION 1 GRANTED

10/25/2023

EXT1

SOU EXTENSION 1 FILED

10/25/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/25/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/07/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/07/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/07/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/02/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/07/2023

PUBO

PUBLISHED FOR OPPOSITION

03/07/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/27/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/16/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/15/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/15/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/13/2022

GNRT

NON-FINAL ACTION E-MAILED

09/13/2022

CNRT

NON-FINAL ACTION WRITTEN

09/13/2022

DOCK

ASSIGNED TO EXAMINER

09/07/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/15/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/14/2022

NWAP

NEW APPLICATION ENTERED

01/11/2022

Continuous trademark protection

Get notified about every new filing that threatens ARCELLX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.